NK cell subsets and their role in allergy

Bibliography

• Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol 2005;17:29-35
   PubMed Web of Science ®Google Scholar
• Herberman RB. Natural killer cells. Annu Rev Med 1986;37:347-52
   PubMed Web of Science ®Google Scholar
• Larosa DF, Orange JS. 1. Lymphocytes. J Allergy Clin Immunol 2008;121(Suppl 2):S364-9; quiz S412
   PubMed Web of Science ®Google Scholar
• Das A, Long EO. Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells. J Immunol 2010;185:4698-704
   PubMed Web of Science ®Google Scholar
• Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol 2005;42:495-9
   PubMed Web of Science ®Google Scholar
• Takeda K, Hayakawa Y, Smyth MJ, Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001;7:94-100
   PubMed Web of Science ®Google Scholar
• Wallin RP, Screpanti V, Michaelsson J, Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 2003;33:2727-35
   PubMed Web of Science ®Google Scholar
• Colonna M. NK cells: new issues and challenges. Eur J Immunol 2008;38:2927-9
   PubMed Web of Science ®Google Scholar
• Caligiuri MA. Human natural killer cells. Blood 2008;112:461-9
   PubMed Web of Science ®Google Scholar
• Zwirner NW, Domaica CI. Cytokine regulation of natural killer cell effector functions. Biofactors 2010;36:274-88
   PubMed Web of Science ®Google Scholar
• Shimizu K, Fujii S. DC therapy induces long-term NK reactivity to tumors via host DC. Eur J Immunol 2009;39:457-68
   PubMed Web of Science ®Google Scholar
• Loza MJ, Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2001;2:917-24
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376
   PubMed Web of Science ®Google Scholar
• Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006;118:1-10
   PubMed Web of Science ®Google Scholar
• Hanna J, Bechtel P, Zhai Y, Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 2004;173:6547-63
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93
   PubMed Web of Science ®Google Scholar
• Moretta A, Bottino C, Vitale M, Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223
   PubMed Web of Science ®Google Scholar
• Schleinitz N, March ME, Long EO. Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One 2008;3(9):e3278
   PubMed Web of Science ®Google Scholar
• Gardiner CM. Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet 2008;35:1-8
   PubMed Web of Science ®Google Scholar
• Mandelboim O, Porgador A. NKp46. Int J Biochem Cell Biol 2001;33:1147-50
   PubMed Web of Science ®Google Scholar
• Sivori S, Vitale M, Morelli L, p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med 1997;186:1129-36
   PubMed Web of Science ®Google Scholar
• Vitale M, Bottino C, Sivori S, NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998;187:2065-72
   PubMed Web of Science ®Google Scholar
• Shereck E, Satwani P, Morris E, Cairo MS. Human natural killer cells in health and disease. Pediatr Blood Cancer 2007;49:615-23
   PubMed Web of Science ®Google Scholar
• Arnon TI, Achdout H, Levi O, Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 2005;6:515-23
   PubMed Web of Science ®Google Scholar
• Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009;114:2657-66
   PubMed Web of Science ®Google Scholar
• Liu D, Bryceson YT, Meckel T, Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 2009;31:99-109
   PubMed Web of Science ®Google Scholar
• Walzer T, Chiossone L, Chaix J, Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007;8:1337-44
   PubMed Web of Science ®Google Scholar
• Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002;195:F9-14
   PubMed Web of Science ®Google Scholar
• Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002;2:957-64
   PubMed Web of Science ®Google Scholar
• Moretta L, Ferlazzo G, Bottino C, Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006;214:219-28
   PubMed Web of Science ®Google Scholar
• Zanoni I, Granucci F, Foti M, Ricciardi-Castagnoli P. Self-tolerance, dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells. Immunol Lett 2007;110:6-17
   PubMed Web of Science ®Google Scholar
• Chauveau A, Aucher A, Eissmann P, Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc Natl Acad Sci USA 2010;107:5545-50
   PubMed Web of Science ®Google Scholar
• Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev 2006;20:123-37
   PubMed Web of Science ®Google Scholar
• Poli A, Michel T, Theresine M, CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009;126:458-65
   PubMed Web of Science ®Google Scholar
• Jonges LE, Albertsson P, van Vlierberghe RL, The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand J Immunol 2001;53:103-10
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-40
   PubMed Web of Science ®Google Scholar
• Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006;176:1517-24
   PubMed Web of Science ®Google Scholar
• Silva A, Andrews DM, Brooks AG, Application of CD27 as a marker for distinguishing human NK cell subsets. Int Immunol 2008;20:625-30
   PubMed Web of Science ®Google Scholar
• Vossen MT, Matmati M, Hertoghs KM, CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008;180:3739-45
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Turner SC, Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 2001;97:3146-51
   PubMed Web of Science ®Google Scholar
• Wei H, Zhang J, Xiao W, Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol 2005;115:841-7
   PubMed Web of Science ®Google Scholar
• Zhang J, Sun R, Liu J, Reverse of NK cytolysis resistance of type 2 cytokine predominant-human tumor cells. Int Immunopharmacol 2006;6:1176-80
   PubMed Web of Science ®Google Scholar
• Wei H, Zheng X, Lou D, Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Mol Immunol 2005;42:1023-31
   PubMed Web of Science ®Google Scholar
• Peritt D, Robertson S, Gri G, Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998;161:5821-4
   PubMed Web of Science ®Google Scholar
• Deniz G, Akdis M, Aktas E, Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur J Immunol 2002;32:879-84
   PubMed Web of Science ®Google Scholar
• Papewalis C, Jacobs B, Wuttke M, IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol 2008;180:1462-70
   PubMed Web of Science ®Google Scholar
• Yu G, Xu X, Vu MD, NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006;203:1851-8
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Myojo-Higuma S, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol 2008;77:14-22
   PubMed Web of Science ®Google Scholar
• Deniz G, Erten G, Kucuksezer UC, Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008;180:850-7
   PubMed Web of Science ®Google Scholar
• Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009;31:15-23
   PubMed Web of Science ®Google Scholar
• Luci C, Reynders A, Ivanov II, Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009;10:75-82
   PubMed Web of Science ®Google Scholar
• Cella M, Fuchs A, Vermi W, A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457:722-5
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol 2008;38:3265-8
   PubMed Web of Science ®Google Scholar
• Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol 2006;18:718-26
   PubMed Web of Science ®Google Scholar
• Akdis M. The cellular orchestra in skin allergy; are differences to lung and nose relevant? Curr Opin Allergy Clin Immunol 2010;10:443-51
   PubMed Web of Science ®Google Scholar
• Canonica GW. Introduction to nasal and pulmonary allergy cascade. Allergy 2002;57(Suppl 75):8-12
   PubMed Web of Science ®Google Scholar
• Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003;3:405-12
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis CA, Weigl L, Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol 1997;159:4611-19
   PubMed Web of Science ®Google Scholar
• Akdis M, Simon HU, Weigl L, Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999;163:466-75
   PubMed Web of Science ®Google Scholar
• Aktas E, Akdis M, Bilgic S, Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol 2005;140:301-9
   PubMed Web of Science ®Google Scholar
• von Bubnoff D, Andres E, Hentges F, Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol 2010;125:60-8
   PubMed Web of Science ®Google Scholar
• Wehrmann W, Reinhold U, Kukel S, Selective alterations in natural killer cell subsets in patients with atopic dermatitis. Int Arch Allergy Appl Immunol 1990;92:318-22
   PubMedGoogle Scholar
• Carbone T, Nasorri F, Pennino D, CD56highCD16–CD62L– NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J Immunol 2010;184:1102-10
   PubMed Web of Science ®Google Scholar
• Paust S, Gill HS, Wang BZ, Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010;11:1127-35
   PubMed Web of Science ®Google Scholar
• Mesdaghi M, Vodjgani M, Salehi E, Natural killer cells in allergic rhinitis patients and nonatopic controls. Int Arch Allergy Immunol 2010;153:234-8
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Tomimori Y, Yumoto K, Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 2009;206:1219-25
   PubMed Web of Science ®Google Scholar
• Han X, Fan Y, Wang S, NK cells contribute to intracellular bacterial infection-mediated inhibition of allergic responses. J Immunol 2008;180:4621-8
   PubMed Web of Science ®Google Scholar
• Scordamaglia F, Balsamo M, Scordamaglia A, Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol 2008;121:479-85
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Fuchs A, NK cell and DC interactions. Trends Immunol 2004;25:47-52
   PubMed Web of Science ®Google Scholar
• Vitale M, Della Chiesa M, Carlomagno S, NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005;106:566-71
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-52
   PubMed Web of Science ®Google Scholar
• Eyerich K, Foerster S, Rombold S, Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 2008;128:2640-5
   PubMed Web of Science ®Google Scholar
• Nograles KE, Zaba LC, Shemer A, IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009;123:1244-52 e2
   PubMed Web of Science ®Google Scholar
• Vivier E, Spits H, Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol 2009;9:229-34
   PubMed Web of Science ®Google Scholar
• Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010;107:10961-6
   PubMed Web of Science ®Google Scholar